c‐Src inhibitor selectively inhibits triple‐negative breast cancer overexpressed Vimentin in vitro and in vivo
Longquan Lou(Jiangsu Province Hospital), Yi Zhao(Jiangsu Province Hospital), Yue Wang(Beijing Graphene Institute), Ziyi Yu(Nanjing Medical University), Shui Wang(Jiangsu Provincial Academy of Environmental Science)
Cited by 30
Related Papers
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
|Signal Transduction and Targeted Therapy|2022|257
China’s Soil Pollution Control: Choices and Challenges
|Environmental Science & Technology|2016|122
Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer
|Journal of Translational Medicine|2017|82
ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner
|Molecular Cancer|2024|79
Influence of <scp>ABO</scp> blood group and <scp>R</scp>hesus factor on breast cancer risk: A meta‐analysis of 9665 breast cancer patients and 244 768 controls
|Asia-Pacific Journal of Clinical Oncology|2013|61